Anavex Life Sciences Corp (AVXL)

Working Capital Ratio

93.60%

Quarterly · Period ending:

AVXL logo

AVXL Working Capital Ratio

Latest reported93.60%
AVXL Quarterly Working Capital Ratio (-2663.25% → 93.60%)
High-resolution chart · PNG

AVXL working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anavex Life Sciences Corp Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
93.5974%
94.518%
95.2094%
91.3827%
87.5605%
85.1621%
89.4166%
88.7111%
91.6953%
93.2352%
91.5614%
91.8814%
92.9946%
91.1919%
91.0712%
93.3116%
94.0803%
94.9642%
93.2894%
93.3185%
94.4275%
90.7101%
85.2147%
78.8501%
78.0299%
79.9203%
82.6123%
80.1034%
79.5717%
68.9992%
77.9328%
83.8489%
87.8279%
86.4839%
89.9418%
86.9362%
93.9496%
90.7979%
89.4856%
65.8592%
77.9251%
79.9221%
81.9352%
82.7935%
87.5268%
75.9584%
79.8575%
80.3713%
67.5812%
71.3014%
-1,108.3718%
-396.293%
-102,108.1609%
-705,295.2772%
-4,166.2065%
-21,863.8105%
-9,933.7158%
-1,533.1549%
-2,935.5455%
-563.8513%
-76.3167%
-1,900.1573%
-19.8756%
-898.6879%
-403.818%
-1,948.8103%
-6,000.589%
-903.3592%
-345.6234%
-4,022.2513%
-198,978.1385%
-31,763.8454%
-1,594.1635%
-1,177.1961%
-337.0618%
-1,850,016%
-382,844.9153%
-1,310.8108%
-615.7219%
-124.1377%
-49.072%
-29,032.3077%
-25,447.6923%
-2,663.2549%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.